E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/15/2012 in the Prospect News PIPE Daily.

Mela Sciences plans $20 million at-the-market equity sales agreement

Cowen and Co. will be the agent for the equity offering arrangement

By Devika Patel

Knoxville, Tenn., June 15 - Mela Sciences, Inc. negotiated a $20 million at-the-market equity offering agreement with agent Cowen and Co., LLC on June 15, according to an 8-K filed Friday with the Securities and Exchange Commission.

Mela is an Irvington, N.Y., medical device company that develops non-invasive tools for the detection of melanoma.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.